Friday, August 01, 2025 | 02:26 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Dr Lal Pathlabs Ltd News

We aim to test 500,000 patients a day in 5 years: Dr Lal PathLabs CMD_63455

Dr Lal PathLabs is India's largest diagnostic services player by revenue, with 289 laboratories across the country

We aim to test 500,000 patients a day in 5 years: Dr Lal PathLabs CMD_63455
Updated On : 19 May 2022 | 6:06 AM IST

Dr Lal Pathlabs slips 6%, hits 52-week low post muted Q4 results_63937

In Q4FY22, normalised earnings before interest, taxes, depreciation, and amortization (EBITDA) margins contracted 630 bps to 19.4 per cent from 25.7 per cent in Q4FY21

Dr Lal Pathlabs slips 6%, hits 52-week low post muted Q4 results_63937
Updated On : 18 May 2022 | 9:51 AM IST

Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%_63765

Operating revenue rose 12.7% during the quarter to Rs 485.5 cr; Covid-19 and allied segments added roughly 13.6% to Q4 top line

Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%_63765
Updated On : 17 May 2022 | 7:34 PM IST

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210

The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%_210
Updated On : 26 Nov 2021 | 1:59 PM IST